GMO TECH Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

GMO TECH has a total shareholder equity of ¥970.0M and total debt of ¥245.0M, which brings its debt-to-equity ratio to 25.3%. Its total assets and total liabilities are ¥2.5B and ¥1.6B respectively. GMO TECH's EBIT is ¥780.0M making its interest coverage ratio 390. It has cash and short-term investments of ¥1.1B.

Belangrijke informatie

25.3%

Verhouding schuld/eigen vermogen

JP¥245.00m

Schuld

Rente dekkingsratio390x
ContantJP¥1.15b
AandelenJP¥970.00m
Totaal verplichtingenJP¥1.57b
Totaal activaJP¥2.54b

Recente financiële gezondheidsupdates

Recent updates

Here's Why We Think GMO TECH (TSE:6026) Is Well Worth Watching

Sep 13
Here's Why We Think GMO TECH (TSE:6026) Is Well Worth Watching

GMO TECH, Inc. (TSE:6026) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 10
GMO TECH, Inc. (TSE:6026) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Is GMO TECH (TSE:6026) A Risky Investment?

Aug 02
Is GMO TECH (TSE:6026) A Risky Investment?

GMO TECH, Inc. (TSE:6026) Soars 33% But It's A Story Of Risk Vs Reward

Feb 27
GMO TECH, Inc. (TSE:6026) Soars 33% But It's A Story Of Risk Vs Reward

Analyse van de financiële positie

Kortlopende schulden: 6026's short term assets (¥2.3B) exceed its short term liabilities (¥1.4B).

Langlopende schulden: 6026's short term assets (¥2.3B) exceed its long term liabilities (¥188.0M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 6026 has more cash than its total debt.

Schuld verminderen: Insufficient data to determine if 6026's debt to equity ratio has reduced over the past 5 years.

Schuldendekking: 6026's debt is well covered by operating cash flow (131.4%).

Rentedekking: 6026's interest payments on its debt are well covered by EBIT (390x coverage).


Balans


Ontdek gezonde bedrijven